NeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaFeverAntineoplastic Combined Chemotherapy ProtocolsTaxoidsGranulocyte Colony-Stimulating FactorDrug Administration SchedulePaclitaxelTreatment OutcomeNeoplasmsInfusions, IntravenousAgranulocytosisMaximum Tolerated DoseDeoxycytidineFever of Unknown OriginCamptothecinCisplatinAntineoplastic Agents, PhytogenicMycosesAntineoplastic AgentsVinblastineFluorouracilHematologic NeoplasmsEpirubicinDoxorubicinThrombocytopeniaHematologic DiseasesCyclophosphamideSurvival AnalysisBacterial InfectionsCarboplatinDisease-Free SurvivalLung NeoplasmsDose-Response Relationship, DrugAnti-Bacterial AgentsOrganoplatinum CompoundsOpportunistic InfectionsLeukopeniaAntibiotic ProphylaxisIfosfamidePenicillanic AcidSurvival RateLeucovorinImmunocompromised HostBreast NeoplasmsNeoplasm MetastasisNauseaMucositisCarcinoma, Non-Small-Cell LungEtoposideProspective StudiesAnthracyclinesBacteremiaNeoplasm StagingVincristinePiperacillinLeukocyte CountAdministration, OralAmikacinRetrospective StudiesSalvage TherapyAntifungal AgentsOxonic AcidLymphoma, Non-HodgkinPrednisoneDrug-Related Side Effects and Adverse ReactionsAntimetabolites, AntineoplasticHematologyGuanineTopotecanAlopeciaInfectionRecombinant ProteinsBiosimilar PharmaceuticalsCarcinoma, Small CellTegafurGlutamatesComplement Hemolytic Activity AssayDisease ProgressionMitoxantroneUrologic NeoplasmsThienamycinsFeasibility StudiesDrug Therapy, CombinationRemission InductionAmbulatory CareNeoplasm Recurrence, LocalCombined Modality TherapyGram-Negative Bacterial InfectionsVomitingArea Under CurveBridged CompoundsAmphotericin BChemotherapy, AdjuvantStomatitisAdenocarcinomaTime FactorsCephalosporinsAntibodies, Monoclonal, Murine-Derived